07-18-2018 03:43 PM CET - Health & Medicine

Drug Delivery Devices Market Growth Report 2024 North America Analysis and Forecasts Influenced by Bayer AG, Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Others

Press release from: Data Bridge Market Research
North America Drug Delivery Devices Market
North America Drug Delivery Devices Market
Databridgemarketresearch.com Adds “North America Drug Delivery Devices Market – Trends and Forecast to 2024” To Its Research Database.

Market Analysis:

North America Drug Delivery Devices Market is expected to reach USD 699.1 billion by 2024 from USD 490.6 billion in 2016, at a CAGR of 4.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Download exclusive PDF sample report @ databridgemarketresearch.com/request-a-sample/?dbmr=north...

North America Drug Delivery Devices Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2024

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Frequently Asked Questions?

• What will the market size be in 2024?
• What are the key factors driving the global market?
• What are the challenges to market growth?
• Who are the key players in the market?
• What are the market opportunities and threats faced by the key players?
• What will be the growth rate in 2024?
• Which strategies are used by top players in North America Drug Delivery Devices Market?

For Customized Reports and Discounts, Mail us @ sopan.gedam@databridgemarketresearch.com

Table of Contents:

1) Introduction
3) Market Overview
• Drivers
• Restraints
5) premium insights
6) North America Drug Delivery Devices Market, by Route of Administration
7) North America Drug Delivery Devices Market, by End-User
8) North America Drug Delivery Devices Market, by Country
• Overview
• North America
• Europe
• Asia-Pacific
• south America
• Middle East and Africa
9) North America Drug Delivery Devices Market, Competitive Analysis
10) company profiles

Get Detailed TOC @ databridgemarketresearch.com/toc/?dbmr=north-america-drug...

Market Segmentation:

• On the basis of route of administration the North America drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups. The Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes. The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable. Based on the route of administration, oral drug delivery market dominates the market in 2015 and in the near future injectable drug delivery market will dominate the North America drug delivery devices market with the largest share in the drug delivery market. Topical drug delivery market is considered to be the fastest growing market with the CAGR of 8.3%.

• The pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.

• Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.

• Nasal drug delivery devices are segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sunlingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.

• On the basis of end users the market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. The hospitals segment dominate the North America drug delivery devices market. Home care settings segment is considered to be the fastest growing market with the CAGR of 5.1%.

• The major factors contributing to the growth of the North America drug delivery devices market are rising prevalence of chronic diseases, growth of biologics, new product launches, drug innovation, technological advancements, and decrease in the level of pain. On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.

• Based on geography the market is segmented into 3 countries U.S., Canada and Mexico. U.S. is expected to dominate the market due to rising prevalence of chronic diseases, large healthcare expenditure, and paradigm shift towards value based reimbursements. U.S. dominates the market and is expected to account for the largest share of 93.2% in 2016. This market to poised to witness the largest share due to the increasing prevalence of chronic diseases, development of biologics and pharmaceutical drugs and devices, increasing patient compliance and patient safety.

View Full Report @ databridgemarketresearch.com/reports/north-america-drug-d...

Some of the major companies operating in this market are:

• Bayer AG
• Johnson & Johnson Services, Inc.
• Novartis AG
• Pfizer, Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc.
• Merck & Co.
• Sanofi
• Antares Pharma
• 3M

Inquiry before Buying @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1133647 • Views: 356
More releasesMore releases

You can edit or delete your press release here: